PHASE-II STUDY OF LOW-DOSE CONTINUOUS INFUSION HOMOHARRINGTONINE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA

被引：0
|
作者：
KANTARJIAN, HM
KEATING, MJ
WALTERS, RS
KOLLER, CA
MCCREDIE, KB
FREIREICH, EJ
机构：
来源：
CANCER | 1989年 / 63卷 / 05期
关键词：
D O I：
10.1002/1097-0142(19890301)63:5<813::AID-CNCR2820630502>3.0.CO;2-V
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：813 / 817
页数：5
相关论文
共 50 条
  • [1] A PHASE-II STUDY OF CONTINUOUS-INFUSION OF TRIMETREXATE IN PATIENTS WITH REFRACTORY ACUTE-LEUKEMIA
    KHERADPOUR, A
    BERMAN, E
    GOKER, E
    LIN, JT
    TONG, WP
    BERTINO, JR
    CANCER INVESTIGATION, 1995, 13 (01) : 36 - 40
  • [2] PHASE-II STUDY OF CONTINUOUS-INFUSION DIAZIQUONE IN RELAPSED REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA
    SCHULMAN, P
    DAVIS, R
    LEE, E
    ELLERTON, J
    STASZWESKI, H
    CANCER TREATMENT REPORTS, 1987, 71 (7-8): : 755 - 757
  • [3] Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia
    Kantarjian, HM
    Talpaz, M
    Smith, TL
    Cortes, J
    Giles, FJ
    Rios, MB
    Mallard, S
    Gajewski, A
    Murgo, A
    Cheson, B
    O'Brien, S
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3513 - 3521
  • [4] A phase II study of homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: A pediatric oncology group study
    Bell, BA
    Chang, MN
    Weinstein, HJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 37 (02): : 103 - 107
  • [5] PHASE-II STUDY OF AMSACRINE AND HIGH-DOSE CYTARABINE FOR RESISTANT ACUTE MYELOGENOUS LEUKEMIA
    DECKER, RW
    HO, WG
    CHAMPLIN, RE
    CANCER TREATMENT REPORTS, 1987, 71 (09): : 881 - 882
  • [6] CONTINUOUS-INFUSION AMSACRINE IN PATIENTS WITH REFRACTORY ACUTE MYELOGENOUS LEUKEMIA
    ESTEY, EH
    KEATING, MJ
    MCCREDIE, KB
    FREIREICH, EJ
    CANCER TREATMENT REPORTS, 1987, 71 (11): : 1113 - 1114
  • [7] VINCRISTINE BY CONTINUOUS INFUSION IN REFRACTORY BREAST-CANCER - A PHASE-II STUDY
    HOPKINS, JO
    JACKSON, DV
    WHITE, DR
    MUSS, HB
    COOPER, MR
    STUART, JJ
    SPURR, CL
    WELLS, HB
    RICHARDS, F
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (05): : 529 - 532
  • [8] Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemia
    Roboz, Gail J.
    Giles, Francis J.
    Ritchie, Ellen K.
    Allen-Bard, Sandra
    Curcio, Tania J.
    Wilkes, Meredith A.
    Park, S. Lani
    Kantarjian, Hagop M.
    Faderl, Stefan
    Ravandi, Farhad
    Kelner, Michael J.
    Feldman, Eric J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 10 - 15
  • [9] PHASE-II TRIAL OF ACLACINOMYCIN IN ACUTE MYELOGENOUS LEUKEMIA (AML)
    CASE, DC
    BOYD, M
    BOVE, LG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 176 - 176
  • [10] PHASE-II TRIAL OF PLICAMYCIN AND HYDROXYUREA IN ACUTE MYELOGENOUS LEUKEMIA
    ARCHIMBAUD, E
    TRONCY, J
    SEBBAN, C
    GUYOTAT, D
    DEVAUX, Y
    FRENCH, M
    MORICEAU, M
    VIALA, JJ
    FIERE, D
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (03) : 223 - 225
12345